CYP2C9*2 is associated with indomethacin treatment failure for patent ductus arteriosus.
Rooney SR, Shelton EL, Aka I, Shaffer CM, Clyman RI, Dagle JM, Ryckman K, Lewis TR, Reese J, Van Driest SL, Kannankeril PJ.
Rooney SR, et al. Among authors: shelton el.
Pharmacogenomics. 2019 Aug;20(13):939-946. doi: 10.2217/pgs-2019-0079.
Pharmacogenomics. 2019.
PMID: 31486736
Free PMC article.